Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Soochow UniversityNo recent work listed

Daoming Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7848-9390; OpenAlex author ID A5045411932. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: 3 papers · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper

Papers 7

  1. Author Correction: Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA. Co-author DOI 10.1038/s41598-021-84394-4↗
  2. Identification of key genes and pathways downstream of the β-catenin-TCF7L1 complex in pancreatic cancer cells using bioinformatics analysis. Last author DOI 10.3892/ol.2019.10444↗
  3. Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA. Co-author DOI 10.1038/srep11836↗
  4. FH535 inhibited metastasis and growth of pancreatic cancer cells. Co-author DOI 10.2147/ott.s82718↗
  5. Tamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling… Co-author DOI 10.3892/ol.2014.2711↗
  6. [Down-regulated expression of PP2A catalytic subunit in pancreatic cancer cells promotes cell growth]. Co-author PMID 24721345↗
  7. Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathwa… Co-author DOI 10.1016/j.ejca.2011.08.014↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Min Tao · 5 shared papers, 2011–2021 · strength 0.29
  2. Mengyao Wu · 3 shared papers, 2015–2021 · strength 0.28
  3. Meng Shen · 3 shared papers, 2015–2021 · strength 0.22
  4. Kai Chen · 3 shared papers, 2011–2021 · strength 0.20
  5. Qiaoming Zhi · 2 shared papers, 2015–2021 · strength 0.18
  6. Wei Li · 1 shared paper, 2021 · strength 0.13
  7. Weiming Duan · 3 shared papers, 2011–2015 · strength 0.11
  8. Mengdan Xu · 1 shared paper, 2019 · strength 0.10
  9. Wei Li · 1 shared paper, 2019 · strength 0.10
  10. Yihang Yuan · 1 shared paper, 2019 · strength 0.10
  11. Jian Zhou · 1 shared paper, 2019 · strength 0.10
  12. Mengyao Wu · 2 shared papers, 2015 · strength 0.09
  13. Zekuan Xu · 2 shared papers, 2011–2014 · strength 0.07
  14. Zheng Chen · 2 shared papers, 2011–2014 · strength 0.07
  15. Wei Li · 1 shared paper, 2015 · strength 0.05
  16. Yixiang Mao · 1 shared paper, 2015 · strength 0.05
  17. Wei Li · 1 shared paper, 2015 · strength 0.05
  18. Xin Xie · 1 shared paper, 2015 · strength 0.05
  19. Lian Lian · 1 shared paper, 2015 · strength 0.05
  20. Wěi Li · 1 shared paper, 2014 · strength 0.04
  21. Wei Li · 1 shared paper, 2011 · strength 0.02
  22. Yi Miao · 1 shared paper, 2011 · strength 0.02
  23. Xiao Han · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.